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Abstract 
Background: We aim to assess the association of empirical dietary (EDIH) and lifestyle (ELIH) index for hyperinsuline-
mia with the risk of insulin resistance, hyperinsulinemia, insulin sensitivity, and β-cell dysfunction in Iranian adults.
Methods: In this prospective study, a total of 1244 men and women aged ≥ 20 years were selected among partici-
pants of the Tehran lipid and glucose study and followed for 3.2 years. Dietary intakes were assessed using a valid 
semi-quantitative food frequency questionnaire. Dietary and lifestyle insulinemic potential indices were calculated 
using dietary intake, body mass index, and physical activity information. Multivariable logistic regression was used to 
estimate the associated risk of a 3-year incidence of insulin-related disorders.
Results: The mean ± SD age and BMI of all eligible participants (42.7% males) were 43.0 ± 13.0 and 27.4 ± 4.9 in 
the study’s baseline. After adjusting for all potential confounders, participants in the highest tertile of ELIH score 
had a greater risk of developing hyperinsulinemia (OR:2.42, 95%CI:1.52–3.86, P for trend =  < 0.001), insulin resist-
ance (OR:2.71, 95%CI:1.75–4.18, P for trend =  < 0.001) and insulin insensitivity (OR:2.65, 95%CI: 1.72–4.10, P for 
trend =  < 0.001) compared with those in the lowest tertile. However, the risk of incident β-cell dysfunction was lower 
in individuals with a higher score of ELIH in comparison to those with the lowest score (OR:0.30, 95%CI:0.19–0.45, P for 
trend =  < 0.001).
Conclusions: Empirical lifestyle index for hyperinsulinemia was directly associated with insulin resistance, insulin 
insensitivity, and hyperinsulinemia and was inversely associated with β-cells dysfunction.
Keywords: EDIH, ELIH, Insulin-related disorders, Insulin resistance, Insulin insensitivity, Hyperinsulinemia, Β-cells 
dysfunction
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Background
Insulin-related disorders address three main conditions 
with complex interrelationships, including Insulin resist-
ance (IR), β-cell dysfunction, and hyperinsulinemia [1–3]. 
IR, as decreased sensitivity of the peripheral tissue cells 
to insulin action, [2] and β-cell dysfunction, identified by 
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β-cells hyposensitivity to glucose or disability to over-
come the insulin demand because of increased periph-
eral tissue resistance, [1] are lead to hyperinsulinemia [3]. 
Persistent hyperinsulinemia and hyperglycemia worsen 
the IR and β-cell dysfunction by forming a defective cycle 
during positive feedback. This situation is considered the 
onset of diabetes mellitus, metabolic syndrome, and car-
diovascular risk [4, 5].
The ability of foods to induce postprandial insulin 
secretion is important for preventing IR and T2DM [6]. 
Previous studies have suggested a possible link between 
nutrients [1, 7] and some specific food items [8, 9] and 
IR and insulin secretion. Because dietary patterns include 
the interaction between several dietary factors and a bet-
ter description of food and disease relationships, several 
studies have been conducted to show the association 
between dietary patterns and indices and insulin home-
ostasis [7, 10–12]. Along with the dietary pattern, other 
lifestyle-related factors, such as obesity and physical 
activity (PA), are independently related to the progres-
sion of insulin-related disorders [13, 14].
Recently, Tabung et  al. proposed two dietary and life-
style insulinemic potential indices to assess the long-term 
ability of the diet and other lifestyle factors to induce 
hyperinsulinemia, including the empirical dietary index 
for hyperinsulinemia (EDIH) and empirical lifestyle index 
for hyperinsulinemia (ELIH) [15]. It has been shown that 
the EDIH provides better predictions about both fasting 
and non-fasting C-peptide concentrations rather than 
dietary insulin index (DII), indicating that the EDIH may 
be better in evaluating the dietary impacts of hyperinsu-
linemia on disease risk. Lee et al., in a recent study, dem-
onstrated that a higher EDIH score is associated with an 
increased risk of type 2 diabetes mellitus (T2DM) [16] 
and long-term weight gain [17]. Also, some other stud-
ies explored the relationship between EDIH and ELIH 
with some diseases related to insulin disorders such as 
colorectal cancer [18], gastrointestinal cancer [19], and 
multiple myeloma [20, 21]. However, no study has been 
conducted to investigate the relationship between indi-
ces of the insulinemic potential of diet and lifestyle with 
insulin-related disorders.
In this study, we aim to assess the association of EDIH 
and ELIH with the risk of IR, hyperinsulinemia, insulin 
sensitivity, and β-cell dysfunction in Iranian adults.
Materials and methods
Study participants
The current study was conducted within the Tehran lipid, 
and glucose study (TLGS), which started in 1999 in Teh-
ran city, and its data are collected prospectively at 3-year 
intervals [22]. The study inclusion criteria included 
age ≥ 20  years, no insulin-related disorders as the 
baseline of study (third examination), having complete 
data on dietary intakes, anthropometric and biochem-
istry variables, no history of myocardial infarction (MI), 
stroke and cancer, no pregnancy, and lactation. Also, the 
exclusion criteria of the current study were over-report-
ing and underreporting on dietary intakes, pregnancy or 
lactation during follow-up, and missing during follow-
up time because of lack of cooperation or other reasons. 
In the third survey of the TLGS (2006–08), of 12 523 
participants, 3462 were randomly selected for dietary 
assessment. For the present study, 1348 men and women 
aged ≥ 20  years were selected with complete insulin 
data. Individuals with a history of MI or stroke or cancer 
(n = 18), those who reported daily energy intakes outside 
the range of 800–4200  kcal/day (n = 63), and pregnant 
and lactating women (n = 25) were excluded; some indi-
viduals fell into more than one exclusion category. Finally, 
1244 participants were followed until Survey IV (2009–
11), with a median follow-up period of 3.2  years (inter-
quartile range [IQR] 2.0–3.0  years). Data were analyzed 
for assessing the association between EDIH and ELIH 
and incidence of insulin-related disorders, including 
hyperinsulinemia (n = 855), IR (n = 730), β-cell dysfunc-
tion (n = 967), and insulin insensitivity (n = 728) after 
excluding the participants who had these insulin-related 
disorders at baseline of the current study (Fig. 1).
Sample size calculation
The sample size for the present study was calculated 
using the G power software 3.1.9.4 version. The mini-
mum sample size for EDIH was 507 participants com-
puted using the 80% power, 5% level of significance, 
OR = 1.87 for the highest vs. lowest categories of EDIH 
for each insulin disorders (this OR previously observed 
for diabetes in participants who were in the highest vs. 
lowest quartiles of EDIH [23]), and the incident rate of 
hyperinsulinemia as nearly 20% that previously reported 
in TLGS study [24]. We used all eligible participants of 
the TLGS study, which was more than 507 participants 
for every insulin disorder as an outcome.
Physical activity assessment
The modified and validated version of the Modified 
Activity Questionnaire (MAQ) for the Iranian popula-
tion was used to assess participants’ PA status. Validity 
was assessed via comparing data between the means of 
2 MAQs and the means of four physical activity records 
with the Spearman correlation coefficients [25]. This 
questionnaire consists of questions in two categories, 
including leisure activities and work-related activities. 
Individuals were asked to report the frequency and time 
spent for these two categories during the past 12 months 
as light, moderate, hard, and very hard intensity. To 
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calculate the level of activities with different intensities, 
each activity was weighed in terms of MET (metabolic 
equivalent) based on their relative intensity. The number 
of times and duration of each activity are recorded in the 
questionnaire. Physical activity level was calculated as the 
amount of MET multiplied by the duration of activity in 
minutes multiplied by the number of activities per week. 
Finally, levels of PA are expressed as metabolic equivalent 
hours per week.
Demographic, anthropometric, and lifestyle measures
Demographic information was assessed by skilled inter-
viewers using a pretested questionnaire. In this question-
naire, participants were asked to collect data on several 
variables including age, sex, smoking status as a current 
smoker (daily or occasionally or ex-smokers) or non-
smokers, educational level (graduated/non- graduated), 
medical history (diabetes, hypertension, myocardial 
infarction, stroke, and cancers), medication use (anti-dia-
betic and glucose-lowering drugs). Weight was measured 
with light clothing and accuracy of up to 100  g using a 
SECA digital weighing scale (Seca 707; Seca Corporation, 
Hanover, Maryland; range, 0.1–150  kg). Height was 
measured in a standing position, without shoes and 
shoulders in normal alignment, using a stadiometer with 
a minimum of 1 mm. Body mass index (BMI) was calcu-
lated as weight (Kg)/height2  (m2).
Biochemical measurements
Blood samples of all subjects were collected after 12–14 h 
of overnight fasting in a steady-state sitting position 
between 7:00 and 9.00 AM., immediately centrifuged 
within 30–45  min of collection. All samples were ana-
lyzed at the TLGS research laboratory on collection using 
Selectra 2 auto-analyzer (Vital Scientific, Spankeren, 
Netherlands). Fasting blood sugar (FBS) was measured 
using an enzymatic colorimetric method with glucose 
oxidase. Inter/intra-assay coefficient variations for FBS 
were both 2.2% for FBS. Fasting Insulin was measured 
via electrochemiluminescence immunoassay (ECLIA), 
using Roche Diagnostics kits and Roche/Hitachi Cobas 
e-411 analyzer (Gmbh, manhim, Germany). Inter- and 
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Fig. 1 The diagram of the study participants in the Tehran Lipid and Glucose Study
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intra-assay coefficient variations for insulin were 1.2 and 
3.5, respectively.
Dietary intake assessment
Dietary intakes were assessed using a valid and reliable 
168-item semi-quantitative food frequency questionnaire 
(FFQ). The FFQ validity was previously fulfilled by com-
paring food groups values derived from the question-
naire with values estimated by twelve 24-h dietary recall 
surveys [26, 27]. This FFQ was a Willett-format ques-
tionnaire contains 168 food items. During a face-to-face 
interview, the frequency of consumption for each food 
item during the past year on a daily, weekly, or monthly 
basis was collected by trained and skilled dieticians. 
According to the most frequently consumed items in 
Iran’s national food consumption survey, the food items 
were chosen. Portion sizes of consumed foods reported 
in domestic measures were then transformed to gram 
scale. The United States Department of Agriculture 
(USDA) food composition table (FCT) is used to com-
pute energy and nutrients content. The Iranian FCT was 
used for some local food items which were not available 
in USDA FCT. Dietary intakes in the third phase (2008–
2011) of TLGS were considered as exposure at baseline.
Calculation of indices
Dietary data derived from FFQ were used to calcu-
late insulinemic scores. Since consumption of alcoholic 
drinks such as wine and liquor is unusual in the Iranian 
population due to religious considerations and was not 
reported in the TLGS study, we do not include them in 
calculating indices. Calculating the EDIH and ELIH has 
been explained elsewhere [2]. As we have no food items 
as low energy beverages and cream soup in our FFQ, we 
exclude them in the calculation.
So we calculated EDIH score with 15 instead of 18 
food parameters in two groups according to their poten-
tial to induce or suppress hyperinsulinemia, including 
processed meat (sausage), red meat (beef, or lamb), fish 
(canned tuna, or fish), margarine, poultry (chicken or tur-
key with or without skin), French fries, high-energy bev-
erages (cola with sugar, carbonated beverages with sugar, 
fruit punch drinks), tomatoes, low-fat dairy products 
(skimmed or low-fat milk and yogurt) and eggs (positive 
association). Furthermore, coffee, green leafy vegetables 
(cabbage, spinach, or lettuce), whole fruits, and high-fat 
dairy products (whole milk, cream, cream cheese, and 
other cheese) (inverse association).
In the same way, the ELIH score was calculated with 
11 instead of 14 dietary and lifestyle factors, including 
BMI, margarine, butter, red meat, and fruit juice (apple 
juice, cantaloupe juice, orange juice, or other fruit juice) 
with a positive association and coffee, whole fruit, PA, 
high-fat dairy products, snacks and salad dressing with 
the inverse association. The food groups’ daily intakes 
(serving size) and lifestyle factors values multiplied by 
specific proposed regression coefficients for weighting. 
Finally, to calculate total scores, all weighted food group 
intakes lifestyle factors were summed and then divided 




Homeostatic Model Assessment of Insulin Resistance 
(HOMA-IR) was used to assess IR (HOMA-IR = FBS 
(mmol/L) × Insulin (μU/mL)/22.5). HOMA-IR ≥ 2.17 
and 1.85 were determined as criteria for IR for men and 
women, respectively.
Hyperinsulinemia
Fasting Insulin concentrations ≥ 9.16 and 11.13 are con-
sidered as criteria for hyperinsulinemia for men and 
women, respectively.
Insulin insensitivity
Homeostatic Model Assessment of Insulin sensi-
tivity (HOMA-S) was used to assess Insulin insen-
sitivity (HOMA-S = (1/HOMA-IR) × 100), where 
HOMA-S ≤ 46.1 and 54.1 are considered as criteria for 
insulin insensitivity for men and women, respectively.
β‑cell dysfunction
It was determined using the Homeostatic Model Assess-
ment of β-cell function (HOMA-β) as follows:
(HOMA-β = Insulin (μU/mL) × 20/FBS 
(mmol/L)—3.5). HOMA-β ≤ 67.1 and 86.2 are defined 
as criteria for β-cell dysfunction for men and women, 
respectively.
Statistical analysis
Data were analyzed using the Statistical Package for 
Social Sciences (version 20.0; SPSS Inc, Chicago, IL). 
Histogram charts and Kolmogorov–Smirnov analysis 
were used to assess the normality of variables. Partici-
pants were categorized according to EDIH and ELIH ter-
tiles cutoff points. Baseline characteristics of individuals 
were expressed for continuous and categorical variables 
as mean ± SD or median (25–75) interfertile range (IQR) 
and percentage, respectively. Trends of qualitative and 
quantitative variables across tertiles of ELIH and EDIH 
ratio (as the median value in each tertile) were tested 
using Chi-square and linear regression. Multivariable 
logistic regression was used to estimate the risk of 3-year 
incidence of insulin-related disorders, with IR, hyperin-
sulinemia, insulin insensitivity, and β-cell dysfunction as 
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dependent variables and the EDIH and ELIH scores as 
independent variables; odds ratio (OR) and 95% confi-
dence interval (CI) were reported. All of the regression 
models were adjusted for age, sex, smoking status, PA, 
BMI, energy intake, education level, hypertension, and 
diabetes. P-values < 0.05 were considered as statistically 
significant. Furthermore, in an additional step, sensitivity 
analysis was performed with excluding individuals with a 
history of diabetes at baseline.
Results
The mean ± SD age and BMI of all eligible participants 
(42.7% males) were 43.0 ± 13.0 and 27.4 ± 4.9, respec-
tively. The median (IQR) EDIH and ELIH of partici-
pants were 0.14 (0.05–0.28) and 1.33 (1.16–1.55). After 
excluding each of the insulin disorders at baseline, during 
3.2 years of follow-up, the incidence of hyperinsulinemia, 
β-cell dysfunction, insulin insensitivity, and IR was 20.0, 
24.5, 29.9, and 30%, respectively.
The baseline characteristics and dietary intakes of par-
ticipants according to tertiles of the ELIH are shown in 
Table  1. The BMI, T2DM, FBS, fasting serum insulin, 
HOMA-IR, HOMA-β, hyperinsulinemia, and insulin 
insensitivity increased significantly across ELIH score 
tertiles. In contrast, male percent, PA level, smoking, 
and percent of graduated participants, HOMA-S, and 
β-cell dysfunction decreased (p for trend =  < 0.05). Also, 
dietary intake of energy, fat, red and processed meat, and 
scores of ELIH and EDIH increased across these tertiles; 
however, dietary intake of carbohydrate, high-fat dairy, 
and fruits decreased across tertiles of ELIH score (p for 
trend < 0.05).
Baseline characteristics and dietary intakes across ter-
tiles of the EDIH among all eligible participants in the 
baseline of the study are presented in Table 2. By increas-
ing the score of EDIH, the male percent, smoking, and 
dietary intakes of energy, fat, low-fat dairy, refined grain, 
red and processed meat, vegetables, and scores of ELIH 
and EDIH increased (p for trend =  < 0.05), whereas, age, 
BMI, percent of hypertension and diabetes, FBS, and die-
tary intake of carbohydrate and high-fat dairy decreased 
(p for trend =  < 0.05).
The association between ELIH and EDIH scores with 
the risk of insulin-related disorders, including hyperinsu-
linemia, IR, β-cell dysfunction, and insulin insensitivity, 
is indicated in Table 3. ELIH score showed a significant 
association with the risk of each insulin-related dis-
order in all adjusted models. In the final model, after 
adjusting for all potential confounders including age, 
sex, smoking status, PA, BMI, energy intake, education 
level, hypertension, and diabetes, participants in the 
highest tertile of ELIH score had a greater risk of devel-
oping hyperinsulinemia (OR:2.42, 95%CI:1.52–3.86, P 
for trend =  < 0.001), IR (OR:2.71, 95%CI:1.75–4.18, P 
for trend =  < 0.001) and insulin insensitivity (OR:2.65, 
95%CI: 1.72–4.10, P for trend =  < 0.001) compared with 
those in the lowest tertile. However, the risk of incident 
β-cell dysfunction was lower in individuals with a higher 
score of ELIH in comparison to those with the lowest 
score (OR:0.30, 95%CI:0.19–0.45, P for trend =  < 0.001). 
We also have assessed the association of EDIH scores 
with the risk of insulin-related disorders. Based on the 
results of all three models (Table  3), there was no sig-
nificant association between EDIH score and risk of 
hyperinsulinemia, IR, β-cell dysfunction, and insulin 
insensitivity.
Also, in sensitivity analysis, the findings of the previ-
ous analysis were repeated while the odds ratios were 
strengthened (Table 4).
Discussion
We investigated the association between EDIH and ELIH 
and insulin-related disorders incidence in the present 
population-based cohort study. Our findings showed a 
142, 171, and 165% higher risk of hyperinsulinemia, IR, 
insulin insensitivity, and 70% lower risk of β-cell dysfunc-
tion among participants in the highest tertile of the ELIH 
score compared with those in the lowest tertile. However, 
in our study, the EDIH score was not associated with the 
risk of the above-mentioned insulin-related disorders.
Nowadays, the assessing of the relationship between 
diet alone or combined with other lifestyle factors and 
risk of various chronic diseases is becoming one of the 
most accepted aspects of nutritional studies because it is 
revealed that this complex involves the interrelationships 
between different key factor and so provide a compre-
hensive insight into this regard [11, 23, 28–31]. Recently, 
EDIH and ELIH proposed to predict the body’s insulin 
response to dietary and lifestyle factors. Since hyperin-
sulinemia has been identified as an early metabolic dys-
function indicator previously [3], several studies explored 
the association of these two indices with the risk of 
chronic diseases, in which impaired insulin balance 
plays an important role in their pathogenesis [16–21]. In 
this regard, a significant association has been observed 
between these indices and the risk of some insulin-
related malignancies, including colorectal cancer [18], 
digestive system cancer [19], and multiple myeloma [20, 
21], previously. Two prospective studies with long-term 
follow-up have also demonstrated that a higher EDIH 
score is associated with an increased risk of diabetes [19] 
and substantial weight gain [20]. However, in our study, 
the findings on the association of EDIH and the risk of 
insulin resistance disorders was not significant, this may 
be due to the fact that the onset of chronic disease symp-
toms may take a long time, and despite its salient features 
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in the development of hyperinsulinemia, this dietary pat-
tern alone cannot predict the risk of insulin-related dis-
orders in the short-term period.
We have observed a strong positive association 
between a higher ELIH score and hyperinsulinemia, IR, 
and insulin insensitivity. ELIH is an index that combined 
two important lifestyle factors, BMI and PA, with diet. 
According to the Tabung et  al. study, People on a diet 
with higher hyperinsulinemic potential are at greater 
risk of substantial long-term weight gain and higher BMI 
than others [17]. Besides, based on previous studies, 
overweight and obesity can increase the risk of IR, com-
pensatory insulin hypersecretion, and the destruction 
of pancreatic beta cells. [32–34]. PA, either directly, by 
increasing the production and secretion of anti-inflam-
matory cytokines that reduce systemic inflammation 
and increase insulin sensitivity in muscles [34, 35], or 
indirectly by helping to lose weight, and also keeping an 
appropriate balance between abdominal and intramuscu-
lar adipose tissue [36], can regulate the insulin response 
Table 1 Baseline characteristics of 1244 participants of study population across tertiles (T) of the empirical lifestyle index for 
hyperinsulinemia
Data are presented as mean ± SD for continuous variable and number (percent) for categorical variables
HOMA-IR Homeostatic Model Assessment for Insulin Resistance, HOMA-B Homeostatic Model Assessment for β-cell function, HOMA-S Homeostatic Model Assessment 
for insulin sensitivity, EDIH Empirical dietary index for hyperinsulinemia, ELIH Empirical lifestyle index for hyperinsulinemia
Empirical lifestyle index for hyperinsulinemia
T1 (n = 412) T2 (n = 411) T3 (n = 411) P for trend
 Age ± years 42.3 ± 14.1 43.1 ± 12.6 43.7 ± 12.0 0.132
 Male (%) 195 (47.3) 183 (44.5) 152 (37.0) 0.008
 Body mass index (kg/m2) 23.5 ± 2.7 26.9 ± 2.7 31.8 ± 4.8  < 0.001
 Physical activity (MET-h/week) 33.0 (14.0–77.3) 21.4 (9.7–47.6) 23.6 (10.0–43.7)  < 0.001
 Current smokers (%) 63 (15.3) 51 (12.4) 37 (9.0) 0.021
 Education Level (graduated), (%) 129 (31.3) 108 (26.3) 78 (19.0)  < 0.001
 Hypertension, n (%) 46 (11.2) 58 (14.1) 67 (16.3) 0.079
 Diabetes, n (%) 23 (5.6) 30 (7.3) 41 (10.0) 0.051
Biochemical data
 Fasting serum insulin(mU/mL) 7.27 ± 4.32 8.59 ± 4.00 11.72 ± 7.24  < 0.001
 Fasting blood sugar (mmol/l) 4.97 ± 1.33 5.1 ± 1.33 5.33 ± 1.53  < 0.001
 HOMA-IR 1.35 (0.95–1.93) 1.76 (1.21–2.40) 2.29 (1.59–3.51)  < 0.001
 HOMA-B 105.7 (73.9–149.2) 120.0 (81.8–167.1) 146.0 (90.6–196.8)  < 0.001
 HOMA-S 83.6 ± 46.7 66.8 ± 42.7 49.9 ± 29.5  < 0.001
 Hyperinsulinemia, n (%) 69 (16.7) 113 (27.5) 204 (49.6)  < 0.001
 Insulin resistance, n (%) 104 (25.2) 157 (38.2) 247 (60.1)  < 0.001
 Insulin insensitivity, n (%) 104 (25.2) 158 (38.4) 248 (60.3)  < 0.001
 β-cell dysfunction, n (%) 109 (26.5) 88 (21.4) 77 (18.7) 0.028
Nutrient Intake
 Energy(Kcal/d) 2202 ± 689 2224 ± 688 2302 ± 757 0.041
 Carbohydrate(% of energy) 59.0 ± 7.0 58.4 ± 6.8 56.2 ± 7.7  < 0.001
 Protein(% of energy) 13.5 ± 2.1 13.7 ± 2.5 13.7 ± 2.5 0.348
 Fat(% of energy) 30.2 ± 6.6 30.4 ± 6.7 32.6 ± 7.7  < 0.001
Food groups
 Low-fat dairy (serving/d) 1.08 ± 0.90 0.97 ± 0.81 1.01 ± 0.80 0.297
 High-fat dairy (serving/d) 1.34 ± 1.04 1.09 ± 0.69 1.06 ± 0.73  < 0.001
 Refined grain(serving/d) 5.17 ± 3.73 5.25 ± 3.96 5.34 ± 3.56 0.524
 Red and processed meat(serving/d) 0.59 ± 0.43 0.80 ± 0.61 1.08 ± 1.00  < 0.001
 Fruits(serving/d) 3.51 ± 2.75 3.33 ± 2.79 3.13 ± 2.37 0.041
 Vegetables(serving/d) 2.88 ± 1.97 2.94 ± 2.07 3.07 ± 2.18 0.197
Insulin scores
 EDIH 0.09 (0.02–0.19) 0.15 (0.06–0.27) 0.20 (0.08–0.44)  < 0.001
 ELIH 1.06 ± 0.12 1.34 ± 0.06 1.70 ± 0.20  < 0.001
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of the body. Therefore, similar to the diet, each BMI 
and PA alone is a stronger predictor of insulin-related 
disorders, and as expected that the ELIH score, which 
addresses the collective contributions of the three fac-
tors, though can better predicts the risk of insulin-related 
disorders rather than the dietary index (EDIH) in the rel-
atively short-term period follow-up of our study.
Despite the other three disorders, our findings showed 
a lower risk of β-cells dysfunction among the partici-
pants in the highest vs. those in the lowest tertiles of 
ELIH scores. According to the definition of HOMA-β, 
the higher ratio of insulin to FBS indicates a better func-
tion of the β-cells, which is what happened in the present 
study. In our study, despite slight changes in FBS with 
increasing the ELIH score, increasing insulin concentra-
tion reduced beta-cell dysfunction incidence. This sug-
gests that a hyperinsulinemic lifestyle may delay beta cell 
destruction for a short or midterm. Previous studies have 
shown that hyperinsulinemia can increase insulin secre-
tion by increasing intracellular signaling and sensitivity of 
Table 2 Baseline characteristics of 1244 participants of study population across tertiles (T) of the empirical dietary index for 
hyperinsulinemia
Data are presented as mean ± SD for continuous variable and number (percent) for categorical variables
HOMA-IR Homeostatic Model Assessment for Insulin Resistance, HOMA-B Homeostatic Model Assessment for β-cell function, HOMA-S Homeostatic Model Assessment 
for insulin sensitivity, EDIH Empirical dietary index for hyperinsulinemia, ELIH Empirical lifestyle index for hyperinsulinemia
Empirical dietary index for hyperinsulinemia
T1(n = 415) T2(n = 415) T3(n = 414) P for trend
 Age ± years 45.7 ± 13.5 42.2 ± 12.5 40.9 ± 12.4  < 0.001
 Male (%) 155 (37.3) 177 (42.7) 199 (48.1) 0.008
 Body mass index (kg/m2) 27.8 ± 4.9 27.6 ± 5.1 26.8 ± 4.7 0.004
 Physical activity (MET-h/week) 27.7 (11.7–55.5) 25.3 (9.6–55.5) 24.3 (11.3–49.0) 0.754
 Current smokers (%) 35 (8.4) 53 (12.8) 63 (15.2) 0.009
 Education Level (graduated), (%) 92 (22.2) 112 (27.0) 116 (28.0) 0.163
 Hypertension, n (%) 71 (17.1) 60 (14.5) 41 (9.9) 0.010
 Diabetes, n (%) 44 (10.6) 31 (7.5) 20 (4.8) 0.008
Biochemical data
 Fasting serum insulin(mU/mL) 9.29 ± 5.40 9.19 ± 6.38 9.06 ± 5.22 0.570
 Fasting blood sugar (mmol/l) 5.23 ± 1.57 5.15 ± 1.45 5.00 ± 1.14 0.017
 HOMA-IR 1.80 (1.25–2.69) 1.70 (1.19–2.58) 1.69 (1.15–2.50) 0.190
 HOMA-B 117.2 (79.2–167.1) 118.8 (81.9–165.6) 127.0 (81.9- 177.8) 0.687
 HOMA-S 65.2 ± 42.2 67.2 ± 44.6 68.0 ± 40.6 0.391
 Hyperinsulinemia, n (%) 123 (29.6) 130 (31.3) 136 (32.9) 0.608
 Insulin resistance, n (%) 186 (44.8) 165 (39.8) 162 (39.1) 0.197
 Insulin insensitivity, n (%) 187 (45.1) 166 (40.0) 162 (39.1) 0.181
 β-cell dysfunction, n (%) 100 (24.1) 88 (21.2) 88 (21.3) 0.527
Nutrient intake
 Energy(Kcal/d) 1990 ± 632 2162 ± 701 2566 ± 682  < 0.001
 Carbohydrate(% of energy) 59.9 ± 7.2 58.4 ± 6.8 55.2 ± 7.0  < 0.001
 Protein(% of energy) 13.4 ± 2.1 13.9 ± 2.3 13.7 ± 2.6 0.056
 Fat(% of energy) 29.4 ± 7.0 30.4 ± 6.7 33.4 ± 6.9  < 0.001
Food groups
 Low-fat dairy (serving/d) 0.86 ± 0.73 1.01 ± 0.79 1.18 ± 0.94  < 0.001
 High-fat dairy (serving/d) 1.33 ± 1.00 1.01 ± 0.67 1.15 ± 0.80 0.030
 Refined grain(serving/d) 4.86 ± 3.77 5.06 ± 3.71 5.81 ± 3.71  < 0.001
 Red and processed meat(serving/d) 0.54 ± 0.41 0.80 ± 0.61 1.13 ± 0.98  < 0.001
 Fruits(serving/d) 3.48 ± 2.92 3.24 ± 2.32 3.25 ± 2.65 0.288
 Vegetables(serving/d) 2.44 ± 1.51 3.02 ± 1.94 3.39 ± 2.54  < 0.001
Insulin scores
 EDIH 0.0 ± 0.06 0.14 ± 0.03 0.45 ± 0.23  < 0.001
 ELIH 1.27 ± 0.27 1.34 ± 0.27 1.48 ± 0.30  < 0.001
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beta cells in response to insulinotropic agents and beta-
cell hypertrophy [37, 38]. In any case, these compensatory 
processes are transient, while following a hyperinsuline-
mic lifestyle, in the long run, increases insulin resistance 
and beta-cell depletion, leading to progressive destruc-
tion and the development of diabetes [39].
This study had several strengths. This is the first 
study that assessed the association of EDIH and ELIH 
with odds of insulin-related disorders to the best of our 
knowledge. The current study’s major other strengths 
were the prospective setting, the use of valid and reli-
able food frequency, and PA questionnaires for dietary 
and PA assessments. On the other side, our study was not 
without limitations. In the present study, Like all nutri-
tional studies using FFQ for dietary assessment, some 
measurement errors are inevitable. The golden standard 
method to assess the β-cells function is the hypergly-
cemic clamp technique, but due to our limitations, the 
best method available for us was the homeostatic model 
assessment. Even though this method seems suitable 
for epidemiologic studies, we tried to cover this limita-
tion through accurate and standard fasting insulin and 
glucose assessment. Also, the length of follow-up in this 
study may not be sufficient to evaluate some insulin-
related outcomes, particularly beta-cell dysfunction. It 
means that if the follow-up period lasting a longer time, 
the findings may be different. For example, most prob-
ably, β-cells dysfunction would be increased instead of 
decrease. Finally, there is possible residual confounding 
that we cannot exclude due to unknown or unmeasured 
factors.
Conclusion
Our finding suggested that a higher ELIH score is asso-
ciated with increased odds of IR, insulin insensitivity, 
hyperinsulinemia, and a decreased risk of β-cells dys-
function. Further epidemiological studies are needed to 
address the role of the insulinemic potential of diet and 
lifestyle in the odds of insulin-related disorders and their 
potential mechanisms.
Table 3 The association between the insulin response dietary and lifestyle indices and incidence of insulin related disorders
a Model 1: adjusted for age and sex
b Model 2: adjusted for model 1 and energy intake, smoking, education level (for both), body mass index and physical activity (only for EDIH)
c Model 3: adjusted for model 2 and baseline diabetes and hypertension
Tertiles of ELIH P_trend Tertiles of EDIH P_trend
T1 T2 T3 T1 T2 T3
Hyperinsulinemia
 Median score 1.04 1.28 1.55 0.01 0.14 0.37
 Case/Total 36/283 63/283 71/282 68/285 45/285 58/285
 Model  1a 1.00 (Ref.) 2.05 (1.29–3.26) 2.46 (1.55–3.90)  < 0.001 1.00 (Ref.) 0.60 (0.38–0.93) 0.74 (0.48–1.14) 0.609
 Model  2b 1.00 (Ref.) 2.06 (1.30–3.28) 2.41 (1.51–3.85)  < 0.001 1.00 (Ref.) 0.61 (0.38–0.95) 0.75 (0.47–1.19) 0.633
 Model  3c 1.00 (Ref.) 2.07 (1.30–3.29) 2.42 (1.52–3.86)  < 0.001 1.00 (Ref.) 0.60 (0.38–0.95) 0.75 (0.47–1.19) 0.618
Insulin resistance
 Median score 1.03 1.27 1.51 0.02 0.15 0.40
 Case/Total 43/242 81/242 93/241 74/244 67/243 76/243
 Model  1a 1.00 (Ref.) 2.28 (1.48–3.51) 2.80 (1.82–4.29)  < 0.001 1.00 (Ref.) 0.98 (0.66–1.48) 1.16 (0.78–1.74) 0.434
 Model  2b 1.00 (Ref.) 2.28 (1.48–3.51) 2.74 (1.78–4.21)  < 0.001 1.00 (Ref.) 0.94 (0.62–1.43) 1.09 (0.70–1.69) 0.495
 Model  3c 1.00 (Ref.) 2.30 (1.49–3.55) 2.71 (1.75–4.18)  < 0.001 1.00 (Ref.) 0.94 (0.62–1.44) 1.09 (0.70–1.70) 0.475
β-cell dysfunction
 Median score 1.09 1.35 1.66 0.02 0.15 0.39
 Case/Total 110/319 72/320 53/320 100/323 67/322 71/322
 Model  1a 1.00 (Ref.) 0.51 (0.35–0.74) 0.31 (0.20–0.46)  < 0.001 1.00 (Ref.) 0.57 (0.39–0.83) 0.70 (0.48–1.01) 0.229
 Model  2b 1.00 (Ref.) 0.51 (0.35–0.75) 0.32 (0.21–0.48)  < 0.001 1.00 (Ref.) 0.60 (0.41–0.88) 0.76 (0.51–1.15) 0.430
 Model  3c 1.00 (Ref.) 0.52 (0.36–0.76) 0.30 (0.19–0.45)  < 0.001 1.00 (Ref.) 0.60 (0.40–0.89) 0.79 (0.52–1.20) 0.437
Insulin insensitivity
 Median score 1.03 1.27 1.51 0.02 0.15 0.40
 Case/Total 43/240 80/241 93/242 74/243 67/243 75/242
 Model  1a 1.00 (Ref.) 2.26 (1.47–3.47) 2.75 (1.79–4.21)  < 0.001 1.00 (Ref.) 0.96 (0.64–1.45) 1.12 (0.75–1.68) 0.497
 Model  2b 1.00 (Ref.) 2.26 (1.47–3.49) 2.69 (1.75–4.13)  < 0.001 1.00 (Ref.) 0.92 (0.60–1.39) 1.03 (0.66–1.59) 0.803
 Model  3c 1.00 (Ref.) 2.28 (1.48–3.53) 2.65 (1.72–4.10)  < 0.001 1.00 (Ref.) 0.92 (0.60–1.40) 1.03 (0.66–1.61) 0.796
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